ULTRAGENYX EUROPE GMBH
Advancing transformative medicines for rare and ultra-rare genetic diseases globally.
Overview
- 1–4
- Employees
- Unknown
- Revenue
- 2022
- Founded
Key Decision Makers
Emil D. Kakkis
Chief Executive Officer and President
Description
Ultragenyx is a dedicated biopharmaceutical company focused on transforming the lives of individuals living with rare and ultra-rare genetic diseases. The organization commits itself daily to the development and delivery of novel treatments where none currently exist. They achieve this by exploring...